BIOLASE, Inc. (BIOL)
USD 0.02
(27.39%)
USD 0.02
(27.39%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 49.16 Million USD | 1.45% |
| 2022 | 48.46 Million USD | 23.67% |
| 2021 | 39.18 Million USD | 72.03% |
| 2020 | 22.78 Million USD | -39.73% |
| 2019 | 37.79 Million USD | -18.1% |
| 2018 | 46.15 Million USD | -1.64% |
| 2017 | 46.92 Million USD | -9.43% |
| 2016 | 51.81 Million USD | 6.88% |
| 2015 | 48.47 Million USD | 1.72% |
| 2014 | 47.65 Million USD | -15.55% |
| 2013 | 56.43 Million USD | -1.61% |
| 2012 | 57.35 Million USD | 17.39% |
| 2011 | 48.85 Million USD | 86.3% |
| 2010 | 26.22 Million USD | -39.5% |
| 2009 | 43.34 Million USD | -32.93% |
| 2008 | 64.62 Million USD | -3.38% |
| 2007 | 66.88 Million USD | -4.03% |
| 2006 | 69.7 Million USD | 12.46% |
| 2005 | 61.98 Million USD | 2.19% |
| 2004 | 60.65 Million USD | 23.57% |
| 2003 | 49.08 Million USD | 68.09% |
| 2002 | 29.19 Million USD | 63.24% |
| 2001 | 17.88 Million USD | 85.22% |
| 2000 | 9.65 Million USD | 37.88% |
| 1999 | 7 Million USD | 366.95% |
| 1998 | 1.5 Million USD | -16.67% |
| 1997 | 1.8 Million USD | 157.14% |
| 1996 | 700 Thousand USD | -41.67% |
| 1995 | 1.2 Million USD | 9.09% |
| 1994 | 1.1 Million USD | -54.17% |
| 1993 | 2.4 Million USD | -56.36% |
| 1992 | 5.5 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 10.13 Million USD | -24.9% |
| 2024 Q2 | 11.55 Million USD | 14.06% |
| 2023 Q3 | 10.92 Million USD | -23.55% |
| 2023 Q1 | 10.46 Million USD | -25.51% |
| 2023 Q4 | 13.49 Million USD | 23.52% |
| 2023 FY | 49.16 Million USD | 1.45% |
| 2023 Q2 | 14.28 Million USD | 36.49% |
| 2022 Q2 | 12.23 Million USD | 20.35% |
| 2022 Q4 | 14.05 Million USD | 16.99% |
| 2022 FY | 48.46 Million USD | 23.67% |
| 2022 Q3 | 12.01 Million USD | -1.84% |
| 2022 Q1 | 10.16 Million USD | -18.06% |
| 2021 Q3 | 9.53 Million USD | 4.35% |
| 2021 Q4 | 12.4 Million USD | 30.18% |
| 2021 FY | 39.18 Million USD | 72.03% |
| 2021 Q1 | 8.11 Million USD | -4.74% |
| 2021 Q2 | 9.13 Million USD | 12.54% |
| 2020 Q3 | 6.53 Million USD | 122.57% |
| 2020 Q2 | 2.93 Million USD | -38.57% |
| 2020 Q1 | 4.78 Million USD | -53.02% |
| 2020 FY | 22.78 Million USD | -39.73% |
| 2020 Q4 | 8.52 Million USD | 30.3% |
| 2019 Q4 | 10.18 Million USD | 17.77% |
| 2019 FY | 37.79 Million USD | -18.1% |
| 2019 Q2 | 8.64 Million USD | -16.28% |
| 2019 Q1 | 10.32 Million USD | -20.84% |
| 2019 Q3 | 8.64 Million USD | 0.01% |
| 2018 Q1 | 10.02 Million USD | -20.69% |
| 2018 FY | 46.15 Million USD | -1.64% |
| 2018 Q4 | 13.04 Million USD | 19.28% |
| 2018 Q3 | 10.93 Million USD | -10.02% |
| 2018 Q2 | 12.15 Million USD | 21.3% |
| 2017 Q1 | 10.87 Million USD | -20.98% |
| 2017 Q3 | 10.8 Million USD | -14.32% |
| 2017 Q4 | 12.63 Million USD | 16.92% |
| 2017 FY | 46.92 Million USD | -9.43% |
| 2017 Q2 | 12.61 Million USD | 15.98% |
| 2016 FY | 51.81 Million USD | 6.88% |
| 2016 Q4 | 13.76 Million USD | 4.02% |
| 2016 Q3 | 13.22 Million USD | -4.21% |
| 2016 Q2 | 13.81 Million USD | 25.43% |
| 2016 Q1 | 11.01 Million USD | -24.16% |
| 2015 Q3 | 11.23 Million USD | -5.35% |
| 2015 Q4 | 14.51 Million USD | 29.22% |
| 2015 FY | 48.47 Million USD | 1.72% |
| 2015 Q2 | 11.86 Million USD | 9.34% |
| 2015 Q1 | 10.85 Million USD | -18.0% |
| 2014 FY | 47.65 Million USD | -15.55% |
| 2014 Q2 | 10.18 Million USD | -11.56% |
| 2014 Q3 | 12.71 Million USD | 24.82% |
| 2014 Q4 | 13.23 Million USD | 4.12% |
| 2014 Q1 | 11.51 Million USD | -24.43% |
| 2013 Q4 | 15.24 Million USD | 23.46% |
| 2013 Q3 | 12.34 Million USD | -13.35% |
| 2013 Q2 | 14.24 Million USD | -2.4% |
| 2013 Q1 | 14.59 Million USD | -23.5% |
| 2013 FY | 56.43 Million USD | -1.61% |
| 2012 FY | 57.35 Million USD | 17.39% |
| 2012 Q4 | 19.08 Million USD | 38.45% |
| 2012 Q3 | 13.78 Million USD | 3.49% |
| 2012 Q2 | 13.31 Million USD | 8.08% |
| 2012 Q1 | 12.32 Million USD | -6.36% |
| 2011 Q1 | 10.56 Million USD | 8.67% |
| 2011 Q2 | 12.07 Million USD | 14.37% |
| 2011 Q3 | 13.06 Million USD | 8.13% |
| 2011 Q4 | 13.15 Million USD | 0.74% |
| 2011 FY | 48.85 Million USD | 86.3% |
| 2010 Q3 | 6.22 Million USD | 5.57% |
| 2010 Q4 | 9.71 Million USD | 56.24% |
| 2010 Q1 | 4.39 Million USD | -57.54% |
| 2010 FY | 26.22 Million USD | -39.5% |
| 2010 Q2 | 5.89 Million USD | 34.06% |
| 2009 Q4 | 10.35 Million USD | -14.35% |
| 2009 Q2 | 14.31 Million USD | 117.12% |
| 2009 FY | 43.34 Million USD | -32.93% |
| 2009 Q3 | 12.08 Million USD | -15.59% |
| 2009 Q1 | 6.59 Million USD | -43.33% |
| 2008 Q2 | 18.66 Million USD | -1.99% |
| 2008 Q1 | 19.04 Million USD | -8.63% |
| 2008 Q3 | 15.28 Million USD | -18.09% |
| 2008 FY | 64.62 Million USD | -3.38% |
| 2008 Q4 | 11.63 Million USD | -23.88% |
| 2007 Q3 | 12.81 Million USD | -29.52% |
| 2007 FY | 66.88 Million USD | -4.03% |
| 2007 Q2 | 18.17 Million USD | 20.7% |
| 2007 Q1 | 15.06 Million USD | -24.12% |
| 2007 Q4 | 20.84 Million USD | 62.66% |
| 2006 Q1 | 16.88 Million USD | -10.96% |
| 2006 FY | 69.7 Million USD | 12.46% |
| 2006 Q3 | 17.06 Million USD | 7.29% |
| 2006 Q4 | 19.84 Million USD | 16.3% |
| 2006 Q2 | 15.9 Million USD | -5.76% |
| 2005 FY | 61.98 Million USD | 2.19% |
| 2005 Q4 | 18.95 Million USD | 62.66% |
| 2005 Q3 | 11.65 Million USD | -19.8% |
| 2005 Q2 | 14.53 Million USD | -13.67% |
| 2005 Q1 | 16.83 Million USD | -12.44% |
| 2004 FY | 60.65 Million USD | 23.57% |
| 2004 Q3 | 12.03 Million USD | -18.69% |
| 2004 Q1 | 14.42 Million USD | -10.35% |
| 2004 Q2 | 14.8 Million USD | 2.63% |
| 2004 Q4 | 19.22 Million USD | 59.7% |
| 2003 FY | 49.08 Million USD | 68.09% |
| 2003 Q2 | 10.35 Million USD | 19.51% |
| 2003 Q1 | 8.66 Million USD | -8.71% |
| 2003 Q3 | 13.43 Million USD | 29.68% |
| 2003 Q4 | 16.09 Million USD | 19.77% |
| 2002 Q2 | 7.16 Million USD | 36.9% |
| 2002 Q4 | 9.49 Million USD | 29.82% |
| 2002 Q1 | 5.23 Million USD | -9.72% |
| 2002 Q3 | 7.31 Million USD | 2.15% |
| 2002 FY | 29.19 Million USD | 63.24% |
| 2001 FY | 17.88 Million USD | 85.22% |
| 2001 Q3 | 4.67 Million USD | 7.85% |
| 2001 Q1 | 3.08 Million USD | -16.33% |
| 2001 Q2 | 4.33 Million USD | 40.64% |
| 2001 Q4 | 5.79 Million USD | 23.89% |
| 2000 Q1 | 1.52 Million USD | -15.37% |
| 2000 Q4 | 3.68 Million USD | 68.45% |
| 2000 FY | 9.65 Million USD | 37.88% |
| 2000 Q3 | 2.18 Million USD | -3.17% |
| 2000 Q2 | 2.25 Million USD | 47.92% |
| 1999 FY | 7 Million USD | 366.95% |
| 1999 Q1 | 1.8 Million USD | 100.0% |
| 1999 Q2 | 1.4 Million USD | -22.22% |
| 1999 Q3 | 2 Million USD | 42.86% |
| 1999 Q4 | 1.8 Million USD | -9.79% |
| 1998 Q1 | 300 Thousand USD | -50.0% |
| 1998 FY | 1.5 Million USD | -16.67% |
| 1998 Q2 | 200 Thousand USD | -33.33% |
| 1998 Q3 | 100 Thousand USD | -50.0% |
| 1998 Q4 | 900 Thousand USD | 800.0% |
| 1997 Q1 | 100 Thousand USD | -66.67% |
| 1997 FY | 1.8 Million USD | 157.14% |
| 1997 Q4 | 600 Thousand USD | 0.0% |
| 1997 Q3 | 600 Thousand USD | 50.0% |
| 1997 Q2 | 400 Thousand USD | 300.0% |
| 1996 Q2 | 200 Thousand USD | 100.0% |
| 1996 Q1 | 100 Thousand USD | -50.0% |
| 1996 FY | 700 Thousand USD | -41.67% |
| 1996 Q4 | 300 Thousand USD | 200.0% |
| 1996 Q3 | 100 Thousand USD | -50.0% |
| 1995 Q4 | 200 Thousand USD | -50.0% |
| 1995 Q2 | 400 Thousand USD | 100.0% |
| 1995 Q1 | 200 Thousand USD | 100.0% |
| 1995 Q3 | 400 Thousand USD | 0.0% |
| 1995 FY | 1.2 Million USD | 9.09% |
| 1994 Q2 | 700 Thousand USD | 250.0% |
| 1994 Q4 | 100 Thousand USD | -50.0% |
| 1994 Q3 | 200 Thousand USD | -71.43% |
| 1994 Q1 | 200 Thousand USD | -75.0% |
| 1994 FY | 1.1 Million USD | -54.17% |
| 1993 Q4 | 800 Thousand USD | 100.0% |
| 1993 FY | 2.4 Million USD | -56.36% |
| 1993 Q3 | 400 Thousand USD | -33.33% |
| 1993 Q2 | 600 Thousand USD | 0.0% |
| 1993 Q1 | 600 Thousand USD | -60.0% |
| 1992 FY | 5.5 Million USD | 0.0% |
| 1992 Q4 | 1.5 Million USD | 25.0% |
| 1992 Q2 | 1.7 Million USD | 21.43% |
| 1992 Q3 | 1.2 Million USD | -29.41% |
| 1992 Q1 | 1.4 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -307.695% |
| BrainsWay Ltd. | 31.78 Million USD | -54.677% |
| Cerus Corporation | 156.36 Million USD | 68.559% |
| Envoy Medical, Inc. | 316 Thousand USD | -15458.228% |
| electroCore, Inc. | 16.03 Million USD | -206.7% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -7534.161% |
| IceCure Medical Ltd | 3.22 Million USD | -1422.577% |
| Inogen, Inc. | 315.66 Million USD | 84.425% |
| OrthoPediatrics Corp. | 148.73 Million USD | 66.945% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -1924.876% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -13369.626% |
| MaxCyte, Inc. | 41.28 Million USD | -19.076% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -2418.079% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -44292.675% |
| Orthofix Medical Inc. | 746.64 Million USD | 93.415% |
| PAVmed Inc | 2.45 Million USD | -1905.057% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -118.322% |
| RxSight, Inc. | 89.07 Million USD | 44.807% |
| Sight Sciences, Inc. | 81.05 Million USD | 39.346% |
| SI-BONE, Inc. | 138.88 Million USD | 64.601% |
| TELA Bio, Inc. | 58.45 Million USD | 15.891% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 73.726% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -256.235% |
| Acutus Medical, Inc. | 7.16 Million USD | -586.265% |
| Talis Biomedical Corporation | 412 Thousand USD | -11833.01% |
| Spectral AI, Inc. | 18.05 Million USD | -172.286% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -396.355% |
| CVRx, Inc. | 39.29 Million USD | -25.115% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -4975.224% |
| Bioventus Inc. | 512.34 Million USD | 90.404% |
| Venus Concept Inc. | 76.35 Million USD | 35.61% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -165.593% |
| LivaNova PLC | 1.15 Billion USD | 95.738% |
| 908 Devices Inc. | 50.22 Million USD | 2.12% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 89.806% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -63712.886% |
| NeuroPace, Inc. | 65.42 Million USD | 24.85% |
| LENSAR, Inc. | 42.16 Million USD | -16.602% |
| Apyx Medical Corporation | 52.34 Million USD | 6.084% |
| Cutera, Inc. | 212.36 Million USD | 76.85% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -47.383% |
| BioSig Technologies, Inc. | 18 Thousand USD | -273033.333% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 70.501% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -105.235% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 96.811% |
| Axonics, Inc. | 366.37 Million USD | 86.581% |
| Outset Medical, Inc. | 130.37 Million USD | 62.291% |
| IRIDEX Corporation | 51.86 Million USD | 5.215% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 63.901% |
| IRadimed Corporation | 65.56 Million USD | 25.012% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -4080.612% |
| INVO Bioscience, Inc. | 3.02 Million USD | -1527.637% |
| Telesis Bio, Inc. | 27.5 Million USD | -78.72% |
| Viemed Healthcare, Inc. | 183 Million USD | 73.136% |
| Varex Imaging Corporation | 811 Million USD | 93.938% |
| Quipt Home Medical Corp. | 221.74 Million USD | 77.828% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 28.411% |
| Dynatronics Corporation | 32.53 Million USD | -51.116% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -466.536% |
| Semler Scientific, Inc. | 68.18 Million USD | 27.895% |
| InMode Ltd. | 492.04 Million USD | 90.008% |
| Bruker Corporation | 2.96 Billion USD | 98.342% |
| Cytosorbents Corporation | 36.34 Million USD | -35.254% |
| DexCom, Inc. | 3.62 Billion USD | 98.643% |
| Align Technology, Inc. | 3.86 Billion USD | 98.727% |
| Viveve Medical, Inc. | 6.42 Million USD | -665.079% |
| ZimVie Inc. | 457.43 Million USD | 89.252% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 74.528% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -44292.675% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 93.425% |
| Profound Medical Corp. | 7.33 Million USD | -570.63% |
| Insulet Corporation | 1.69 Billion USD | 97.103% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 61.005% |
| iCAD, Inc. | 17.31 Million USD | -183.89% |
| Nuwellis, Inc. | 8.86 Million USD | -454.648% |
| Biotricity, Inc. | 12.06 Million USD | -307.549% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 90.021% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -692.329% |
| PAVmed Inc. | 2.45 Million USD | -1905.057% |
| Beyond Air, Inc. | 1.15 Million USD | -4141.933% |
| FONAR Corporation | 102.88 Million USD | 52.214% |
| AxoGen, Inc. | 159.01 Million USD | 69.082% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 82.085% |
| Inari Medical, Inc. | 493.63 Million USD | 90.04% |
| UFP Technologies, Inc. | 400.07 Million USD | 87.711% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -264222.581% |
| Tenon Medical, Inc. | 2.92 Million USD | -1579.098% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -621.722% |
| AdaptHealth Corp. | 3.2 Billion USD | 98.464% |
| Sintx Technologies, Inc. | 2.62 Million USD | -1771.488% |
| NanoVibronix, Inc. | 2.28 Million USD | -2053.482% |
| Quanterix Corporation | 122.36 Million USD | 59.823% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -101.451% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 75.482% |
| TransMedics Group, Inc. | 241.62 Million USD | 79.653% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -254.872% |
| NeuroMetrix, Inc. | 5.9 Million USD | -733.087% |
| Hyperfine, Inc. | 11.03 Million USD | -345.649% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 70.231% |
| Biomerica, Inc. | 5.41 Million USD | -807.922% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 2.763% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 72.245% |